drug

sorafenib

1 story · latest Nov 3, 2026

Follow sorafenib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Dec 2005 · NDA021923
Brand: Nexavar
Trials: 3 registered trials in coverage

Relationships

Developed by Bayer

Timeline

Sorafenib liver transplant trial posts results; Bayer renal study still completed

Nov 3Weekly roundup, 2 itemsBayer sorafenibUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.